Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Reckitt
Reckitt
Activities:
Body Care
Skin Care
Pharmaceutical
X
LinkedIn
Trending Articles
Samsung Biologics signs $1.24bn biopharma manufacturing deal with Asian pharmaceutical giant
The CDMO will work with the client until the end of 2037, and will use its South Korean biomanufacturing site to serve them
Bespak and H&T Presspart announce availability of GMP pilot line for climate-friendly pMDIs
Filling line is on track to supply clinical trial batches utilising climate-friendly propellants HFA-152a and HFO-1234ze
Astellas' Vyloytm plus chemo gains FDA approval for gastric adenocarcinoma
The drug is the first CLDN18.2 targeted therapy to be approved in the US, and can further extend a patient's PFS and OS compared with chemotherapy alone
Axol Bioscience boosts its iPSC bioassay offering with Phenocell acquisition
The acquisition will extend Axol's range of iPSC-derived cell lines, including skin and retinal cells — while also expanding its drug discovery services
How AI and GenAI will revolutionise the healthcare industry
Artificial intelligence — and particularly its newest iteration, generative artificial intelligence (GenAI) — could bring significant changes to the way we live, work and...
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Kemtile appointed as a single-source supplier by Reckitt
Kemtile, a division of Stonhard, has been appointed as a single-source supplier to design and install a new flooring solution for production area corridors at Reckitt (formerly Reckitt Benckiser) in Nottingham, UK
Design & Build
M+W Group starts building RB’s new Centre for Scientific Excellence in UK
Groundwork has already begun on the R&D Centre in Dansom Lane, Hull, that will provide a GMP development facility and pilot plant
Regulatory
Australian Federal Court finds Reckitt Benckiser made misleading claims about content of its painkillers
Orders Nurofen Specific Pain product range to be removed from retail shelves
Finance
Reckitt Benckiser to spin off its pharmaceuticals business
Will be renamed Indivior and continue to concentrate on treatments for opioid addiction
You need to be a subscriber to read this article.
Click here
to find out more.
Regulatory
Competition Law is catching pharma companies out
With major multinationals paying a high price for illegal and corrupt market activities, Paul Henty and Rory Ashmore, of legal firm Speechly Bircham, review the underlying causes and the risks
Media
Reckitt Benckiser licenses Atrigel Technology from QTL
<p>Reckitt Benckiser Pharmaceuticals Inc, based in Richmond, VA, has set up a licensing agreement with QLT USA, for Atrigel sustained-release drug delivery technology.</p>
Subscribe now